<DOC>
	<DOC>NCT00835731</DOC>
	<brief_summary>The purpose of this study is to compare the dilatory effect of 400 mcg of buccally administered misoprostol to one Dilapan-S rod placed 3-4 hours before abortion by dilation and evacuation in women who are 12 weeks 0 days to 15 weeks 0 days gestation.</brief_summary>
	<brief_title>Misoprostol Versus Dilapan-S for Cervical Preparation</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>medically eligible for dilation and evacuation at Planned Parenthood League of Massachusetts gestational age 12 weeks 0 days to 15 weeks 0 days as evaluated by ultrasound proficient in English or Spanish agreeing to study procedures, including randomization and surveys regarding demographics, medical and gynecological history, and assessments of pain and satisfaction less than 18 years old cervical or uterine anomaly that the research physician deems may affect the difficulty of dilation or the abortion procedure inflammatory bowel disease contraindication to misoprostol use known intolerance or allergy to misoprostol or DilapanS inability to give informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>induced abortion</keyword>
	<keyword>misoprostol</keyword>
	<keyword>cervical ripening</keyword>
	<keyword>second trimester abortion</keyword>
	<keyword>Dilapan-S</keyword>
</DOC>